Christopher Clay has extensive experience in the pharmaceutical and healthcare industries, beginning as a Sales Representative at Marion Merrell Dow from 1991 to 1997, focusing on products such as Cardizem, Seldane, and Carafate. Christopher held various leadership roles at notable companies including a recent position as GM Market Access, US Oncology at AbbVie since June 2022. Previous positions include VP Account Management at Mallinckrodt Pharmaceuticals, Regional Account Manager at Sanofi, and roles involving national account leadership responsible for major health plans and payers. Throughout the career, Christopher has demonstrated expertise in account management, contracting, and market access strategies across oncology and other therapeutic areas. Academic credentials include a degree in Business Administration with a focus on Finance from Saint Louis University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices